News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Molecular Coupling of Xist Regulation and Pluripotency
Area: DNA
Pluripotency key factors bind to Xist intron 1 in undifferentiated embryonic stem cells, report research groups from the Pasteur Institute in Paris and the University of Edinburgh, UK. During murine embryogenesis, the imprinted X chromosome inactivation can be reprogrammed in the inner cell mass of a pluripotent female blastocyst. The reversion is triggered by repression of Xist from the paternal X chromosome. The three main genetic factors underlying pluripotency, Nanog, Oct3/4 and Sox2, bind to Xist intron 1.
In Nanog -/- embryonic stem cells, a slight up-regulation of Xist is observed if Oct3/4 and Sox2 binding is normal. The up-regulation is reversible. Release of all three factors from Xist intron 1 results in a rapid ectopic accumulation of Xist RNA.
The three main factors for pluripotency seem to cooperate and repress Xist. X chromosome inactivation reversal is therefore linked to the control of pluripotency during murine embryogenesis.
The three main factors for pluripotency seem to cooperate and repress Xist. X chromosome inactivation reversal is therefore linked to the control of pluripotency during murine embryogenesis.
Related antibodies on antibodies-online.com:
Chromosome X open reading frame 2
Chromosome X open reading frame 6
Antibodies for the research area DNA: »Show antibodies
-

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials -

19.10.2011 International Conference on Ovarian Cancer Screening 2011 -

19.10.2011 Conference: Ensuring the high quality of your clinical data in an era of cost cutting -

06.10.2011 Conference: World Stem Cells & Regenerative Medicine Congress Asia 2011 -

15.09.2011 Conference: Vaccines and Biologics -

15.09.2011 BIT's 4th Annual International Congress of Antibody (ICA2012) -

30.08.2011 Biosimilars and Biobetters conference: Aligning business & science for success -

30.08.2011 Regenerative Medicine: Barriers to commercialisation online summit 2011 -

26.08.2011 World Antibody Focus 2011 -

26.08.2011 SMi’s 10th annual Clinical Trials in CNS conference -

28.07.2011 Cancer Research Global Summit -

22.07.2011 Conference: VacChina 2011 -

21.06.2011 Conference: Your gateway to the Rare Disease market in Asia -

21.06.2011 Conference: Accelerate your stem cell development to commercialization -

25.05.2011 Microscopy Conference 2011

